Antibody Drug Conjugates Market

“Antibody Drug Conjugates Market: Global Industry Analysis, Market Size, Share, Trends, Application Analysis, Growth and Forecast, 2023-2028” provides a deep and thorough evaluation of the antibody drug conjugates market by drugs (adcetris, kadcyla); by mechanism of action (LgG1 antibodies, HER2 antibodies); by technology used ADCs (SGEN, IMGN, IMMU, Others); by application (breast cancer, lymphoma); and by geography (North America, Europe, Asia-Pacific, Latin America and Middle East & Africa).Antibody drug conjugates are biopharmaceutical drugs that are composed of complex molecules of anti-cancer drugs or other cell-killing agents attached to monoclonal antibodies. They are designed to target specific antigens found on target cells, thereby making them highly effective and less prone to causing side effects. They are majorly employed in the healthcare sector for the treatment of a wide variety of medical ailments.

The rising prevalence of cancer across the globe due to the high rates of smoking, alcohol and tobacco consumption has fueled the demand for antibody drug conjugates for their treatment. Furthermore, extensive research and development (R&D) activities related to antibody therapies, advanced drug discoveries and preclinical research are also expected to propel the market growth. 

Antibody Drug Conjugates Market Key Segments:

Segmentation by Drugs:

• Adcetris
• Kadcyla

Segmentation by Mechanism of Action:

• LgG1 antibodies
• HER2 Antibodies

Segmentation by Application:

• Breast Cancer
• Lymphoma

Segmentation by Technology used ADCs 

• SGEN
• IMGN
• IMMU
• Others

 Segmentation by Region:

• Asia-Pacific
• Europe
• Latin America
• North America
• Middle East & Africa

Competitive Landscape:

• Agensys
• Immunogen
• Immunomedics, Inc
• Seattle Genetics Inc.
• Genentech Inc.

The price margins for the products along with the various success and risk factors for manufacturers have also been covered in the report. Moreover, in order to determine market attractiveness, the report analyses the antibody drug conjugates industry along the parameters of the porter’s five forces model. This model examines the degree of competition in the antibody drug conjugates industry by analysing the threat posed by new entrants and substitutes, and the bargaining power of suppliers and buyers. Swot analysis of the market has also been presented in the report which highlights the strengths, weaknesses, opportunities and threats pertaining to the antibody drug conjugates industry. Furthermore, the value chain analysis of the antibody drug conjugates industry has also been covered in the report. This comprises of all the activities in the value chain, such as the procurement of various raw materials, manufacturing and sales of the products, and their distribution.

Highlights of The Antibody Drug Conjugates Market

• Historical and current scenario
• Trends and developments
• Market forecast
• Price analysis and forecast
• Porter’s five forces analysis
• SWOT analysis
• Value chain analysis

The report is a result of exhaustive primary and secondary research undertaken by analysts having years of experience in the antibody drug conjugates industry. All the qualitative and quantitative aspects of the industry have been covered and the collected data has been analysed and presented in the form of easily comprehensible charts, graphs and tables.